United Guardian (UG) Dividends Paid - Common Growth (1y) (2011 - 2026)
Powered by 
Analysis
United Guardian (UG) Dividends Paid - Common Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 3.13% |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 5.50% |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | 3.23% |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | -15.53% |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | 0.25% |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | 14.71% |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | - |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | -86.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -86.82% |
| Mar 31, 2026 | -28.57% |
| Sep 30, 2025 | -28.57% |
| Mar 31, 2025 | 40.00% |
| Sep 30, 2024 | 250.00% |
| Dec 31, 2022 | -52.30% |
| Jun 30, 2022 | -99.98% |
| Dec 31, 2021 | 80.52% |
| Jun 30, 2021 | 14.29% |
| Dec 31, 2020 | -34.57% |
| Jun 30, 2020 | -23.60% |
| Dec 31, 2019 | -0.16% |
| Dec 31, 2018 | -44.93% |
| Dec 31, 2017 | 149.68% |
| Dec 31, 2016 | -19.86% |
| Dec 31, 2015 | 56.25% |
| Dec 31, 2014 | -36.00% |
| Dec 31, 2013 | 128.09% |
| Dec 31, 2012 | -504.55% |
| Dec 31, 2011 | 33.33% |